On the other hand, Cardoso et al. have demonstrated that the incubation of MPN cells with BM-derived stroma impairs the cytotoxic action of vorinostat® and ruxolitinib combination, an effect possibly attributed to the activation of relevant survival pathways, including JNK and PI3K [40]. Here, MAPK8 is linked to myeloproliferative disorder.